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ABSTRACT
Objective: The present study deals with the antioxidant study of one Ayurvedic medicine Aswagandhrishtam by three different methods, namely 
reducing power, 2,2-diphenyl-1-picrylhydrazyl (DPPH), and 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) assays.
Methods: Aswagandharishtam, which is a liquid medicine, was taken as such at various concentrations for all the three assays.
Results: The results show that Aswagandharistam has good antioxidant potential when compared with ascorbic acid as standard. The IC50 values of 
reducing power assay were 250.142, that of DPPH were 103.607, and of ABTS assay were 197.79 as compared with that of ascorbic acid being 19.59.
Conclusion: All the three assays indicated that Aswagandharishtam showed very good antioxidant results.
Keywords: Aswagandharishtam, 2,2’-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid, 2, 2-Diphenyl-1-picrylhydrazyl, Vata, Antioxidant, Epilepsy, 
Ascorbic acid.
INTRODUCTION
The evaluation of the scientific efficacy of Ayurvedic and Siddha 
drugs has become an urgent necessity for their acceptance and 
promotion. Although these systems are in vogue since ages, the 
scientific validation with modern parameters will prove their efficacy 
and help in resurrecting these age-old systems of medicine. This is 
all the more required due to the development of multidrug-resistant 
pathogens and increase in the incidence of dreaded diseases such 
as cancer, malaria, and AIDS, with which the modern medicine is 
unable to cope up with. It will be wise to develop a safe, cost-effective 
medicine which could have less or no side effects. For the past two 
decades, increasing focus is being given by government and private 
players in this direction [1-30]. Ministry of AYUSH, Government of 
India, and other such organizations should come forth to develop 
techniques, protocols, and methods to establish the Ayurvedic and 
Siddha medicines at the global level.
The present study is one step in this direction. The study deals with 
the antioxidant study of Ashwagandharishtam or Aswagandharishtam, 
which is a liquid Ayurvedic medicine used in psychiatric conditions, 
dullness, loss of memory, sluggishness, epilepsy, low digestion power, 
piles, and diseases caused by Vata imbalance. It is also used as nerve 
tonic, for sexual disorders and for depression. Being an Arishta, it 
contains about 5–10 % of self-generated natural alcohol which helps 
in the delivery of the drug in the body. The dosage of this medicine is 
usually 12–24 ml twice daily after food or as advised by the physician.
The present work undertakes the antioxidant assay study of this 
medicine to understand its possible mechanism of action. The 
manufactures of this medicine are Baidyanath, Dabur, AVN, AVP, Vaidik 
Herbs, and Kottakkal Arya Vaidya Sala.
Since this medicine helps in rejuvenation of mind and body, its role as 
an antioxidant should be understood. The present study encompasses 
three antioxidant assays, namely reducing power assay, 2,2-diphenyl-1-
picrylhydrazyl (DPPH) assay, and 2,2’-azino-bis(3ethylbenzothiazolin6-
sulfonic acid (ABTS) assay.
METHODS
This Arishtam is made of the following ingredients which are divided 
into two sections: Kwatha dravyas (Main components) and Prakshepa 
dravyas (additive components).
The coarse powder of Kwatha dravyas (Main components) is added 
with water, boiled and reduced to 12.288 L, and filtered. It is added 
with honey, and Prakshepa Dravya (additive components) powders are 
added and kept in an airtight container for 1 month for fermentation. 
After a month time, it is filtered and preserved.
Aswagandharishtam ingredients:
Kwatha dravyas (main components)
Ashwagandha (Withania somnifera) - Root - 2.4 kg
Mushali (Chlorophytum tuberosum) - Root - 960 g
Manjishta (Rubia cordifolia) - Root - 480 g
Haritaki (Terminalia chebula) - Fruit - 480 g
Nisha - Turmeric - (Curcuma longa) rhizome - 480 g
Daruharidra (Berberis aristata) - Stem - 480 g
Yashtimadhu - Licorice - (Glycyrrhiza glabra) Root - 480 g
Rasna (Pluchea lanceolata) - Root/leaf - 480 g
Vidari (Pueraria tuberosa) - Root - 480 g
Arjuna (Terminalia arjuna) - stem bark - 480 g
Mustaka (Cyperus rotundus) - Rhizome - 480 g
Trivrit (Ipomoea turpethum) - Root - 480 g
Sariva (Indian sarsaparilla - Hemidesmus indicus) - Root - 384 g
Krishna Sariva (Cryptolepis buchanani) - Root - 384 g
Shweta Candana (Santalum album) - heartwood - 384 g
Rakta Candana (Pterocarpus santalinus) - heartwood - 384 g
Vacha (Acorus calamus) - Rhizome - 384 g
Chitraka (Plumbago zeylanica) - Root - 384 g
Water for decoction - 98.304 L
Boiled and reduced to 12.288 L
Madhu - Honey - 14.4 kg
Prakshepa - Dravyas (additive components)
Dhataki - Woodfordia fruticosa - Flower - 768 g
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Shunti - Ginger - (Zingiber officinale) - Rhizome - 96 g
Maricha - Pepper - (Piper nigrum) - Fruit - 96 g
Pippali - Long pepper - (Piper longum) - 96 g 
Twak - Cinnamon - (Cinnamomum zeylanicum) - 192 g
Ela - Cardamom - (Elettaria cardamomum) - 192 g
Patra (Cinnamomum tamala) - leaves – 192 g
Priyangu (Callicarpa macrophylla) - Flower - 192 g
Nagakeshara (Mesua ferrea) - Stamen - 96 g
Aswagandharishtam was procured from Standard Ayurvedic Vendors 
at Chennai.
The drug was subjected to antioxidant assays, namely reducing power, 
DPPH, and ABTS assays.
Reducing power assay [31]
Various concentrations of the Aswagangharishtam in 1 ml of 10% DMSO 
solution was mixed with phosphate buffer (2.5 ml) and potassium 
ferricyanide (2.5 ml) and incubated at 50°C for 20 min. Aliquots of 
trichloroacetic acid (2.5 ml) were added to the mixture, which was 
then centrifuged at 3000 rpm for 10 min. The upper layer of solution 
(2.5 ml) was mixed with distilled water (2.5 ml) and a freshly prepared 
ferric chloride solution (0.5 ml). The absorbance was measured at 
700 nm. A blank was prepared without adding sample or standard. 
Ascorbic acid at various concentrations was used as reference standard. 
Increased absorbance of the reaction mixture indicates an increase in 
reducing power.
% inhibition = [Aswagandharishtam-Control/Aswagandharishtam] 
× 100
DPPH radical scavenging assay [32]
The method described by Oyedemi and Afolayan et al. (2011) was used 
to determine the DPPH scavenging activity of the Aswagandharishtam. 
The solution of 0.135 mM DPPH was prepared in methanol. Different 
concentrations of the medicine (0.1 ml) were mixed with 1.9 ml of DPPH 
solution. The reaction mixture was vortexed thoroughly and left in the 
dark at room temperature for 30 min. The absorbance of the mixture 
was measured at 517 nm. Ascorbic acid was used as the reference drug. 
The ability of the medicine to scavenge DPPH radical was calculated 
from the following formula:
% DPPH inhibition= [(OD of Control - OD of Aswagandharishtam)/(OD 
of Control)] × 100
ABTS radical scavenging assay [33]
A stock solution of ABTS radical cation was prepared by dissolving 
ABTS (7 mM, 25 ml in deionized water) with potassium persulfate 
(K2S2O8) (140 mM, 440 μL). The mixture was left to stand in the dark at 
room temperature for 15–16 h (the time required for the formation of 
the radical) before use. For the evaluation of ABTS radical scavenging 
activity, the working solution was prepared by the previous solution and 
diluting it in ethanol to obtain the absorbency of 0.700±0.02 at 734 nm. 
The solvent extracts and Aswagandharishtam (0.1 ml) at different 
concentrations were mixed with the ABTS working solution (1.9 ml), 
and the reaction mixture was allowed to stand at room temperature for 
20 min; then, the absorbance was measured using a ultraviolet-visible 
spectrophotometer at 734 nm. The radical scavenging activity is given 
as ABTS radical scavenging effect that is calculated by the following 
equation:
ABTS radical scavenging effect (%) = [(OD of Control - OD of 
Aswagandharishtam)/(OD of Control) × 100
RESULTS
Table 1 shows the reducing power assay results. Table 2 shows 
the DDPH assay results and Table 3 shows the ABTS assay results. 
Ascorbic acid was used as a standard to compare the antioxidant 
activities of different assays as shown in Table 4. The comparative 
percentage inhibition of the three assays as compared to ascorbic acid 
is summarized in Fig. 1. The comparative IC50 values (Fig. 2) indicate 
that Aswagandharishtam exhibits excellent antioxidant capacity for all 
the three assays conducted and this could be a very important factor for 
the medicinal role of Aswagandharishtam.
Reducing power assay
The reducing power assay of Aswagandharishtam indicated good 
antioxidant properties as seen by its IC50 value as compared with that of 
ascorbic acid being shown in Fig. 1.
DDPH assay
The DPPH assay of Aswagandharishtam also indicated good antioxidant 
properties as seen by its IC50 value as compared with that of ascorbic 
acid being shown in Fig. 1.
ABTS assay
The ABTS assay of Aswagandharishtam also indicated good antioxidant 
properties as seen by its IC50 value as compared with that of ascorbic 
acid being shown in Fig. 1.
Ascorbic acid
Ascorbic acid was used as a standard to compare the antioxidant 
activities of different assays as shown in Table 4.
DISCUSSION
The present work was in continuation of our studies on the gas 
chromatography-mass spectrometry (GC-MS) and antioxidant profiles 
of various Ayurvedic medicines. Two more Aristaas, studied by us, 
namely Ashokarishtam and Partharishtam, also indicated strong 
antioxidant properties as was understood by the biomolecules present 
as shown in the GC-MS analysis [34-36].
The GC-MS analysis study of a similar medicine, Ajaswagandhadi 
lehyam, in which the major component is Aswagandha (Winter 
cherry/Indian Ginseng (root) - W. somnifera). Withania is reported to 
medicinal values such as immunomodulator, aphrodisiac, antitumor, 
anti-inflammatory, anti-stress, antioxidant, sleep-inducing, effective in 
memory-related conditions, insomnia, hemopoietic effect on CNS, and 
cardiopulmonary systems [37]. The phytoconstituents present in this 
plant such as Withanoside IV or VI produced dendritic outgrowth in 
normal cortical neurons of isolated rat cells, whereas axonal outgrowth 
was observed in the treatment with withanolide A in normal cortical 
Table 1: The reducing power assay results of Aswagandharishtam
S. No Concentration (µg/ml) Absorbance % Inhibition IC50
1 5 0.507 0.507
2 10 0.528 0.528
3 20 0.545 0.545
4 50 0.58 0.58
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neurons [38]. The crude extract of the plant containing the steroidal 
substances sitoindosides VII-X and withaferin A augmented learning 
acquisition and memory in both young and old rats [39].
The present medicine in study, i.e. Aswagandharistam also contains 
Aswagandha as a major component. Among the constituents of 
Aswagandharishtam, some have been reported to have strong 
antioxidant potentials such as C. tuberosum (Baker), R. cordifolia, 
T. chebula, B. aistata, G. glabra, P. tuberose, Operculina turpethum, 
H. indicus, P. santalinus, Z. officinalis, P. longum, P. nigrum, C. tamala, and 
M. ferrea L [40-56]. Thus, the antioxidant properties as shown in this 
present work augur well with similar activities of the majority of its 
constituents.
CONCLUSION
From the above discussion, it is clear that aristaas, in general, have 
antioxidant properties and Aswgandharishtam shows very good 
antioxidant activities with respect to all the three assays, namely reducing 
assay, DPPH assay, and ABTS assay, proving its efficacy as a potent medicine.
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ABTS: 2,2’-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid. SD: Standard deviation
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Fig. 1: The comparative inhibition percentages of all the three 
assays as compared to ascorbic acid (standard)
Fig. 2: The IC50 value comparison of all the three assays as 
compared to ascorbic acid (standard)
230
Asian J Pharm Clin Res, Vol 11, Issue 11, 2018, 227-231
 Kotteswari et al. 
Kumar. Sampad Shil was involved in preparing the graphs and analysis 
of results. All the authors have approved the article.
CONFLICTS OF INTEREST
The authors declare that no conflict of interest exists among them.
REFERENCES
1. Shankari C, Venkatesan V, Rao MR, Saravanan K, Prabhu K, Prakash S. 
The GC MS analysis study of one ayurvedic medicine “Ajaswagandhadi 
lehyam”. Int J Pharm Sci Rev Res 2016;40:33-7.
2. Queen ZE, Rao MR, Anthony J, Prabhu K, Johnson WM, 
Balasubramanian BS, et al. The GC MS study of one ayurvedic 
preparation Amrithamehari Churnam. Int J Pharm Sci Rev Res 
2016;39:169-72.
3. Jessica A, Rao MR, Anthony J, Prabhu K, Johnson WM, 
Balasubramanian BS, et al. The GC-MS study of one ayurvedic 
preparation Katakakhadiradi Kashayam. Int J Pharm Sci Rev Res 
2016;39:216-24.
4. Rao MR, Mohammad H, Narayanan S, Prabhu K, Kalaiselvi VS, Ravi A, 
et al. Antioxidant assay and GC-MS analysis of one Sidha medicine 
Swasa Kudori tablets. Int J Pharm Sci Rev Res 2016;37:19-25.
5. Sivakumaran G, Rao MR, Prabhu K, Kalaiselvi VS, Jones S, 
Johnson WM, et al. Preliminary GC-MS anlaysis and antioxidant study 
of one ayurvedic medicine “Manasa Mitra Vatakam”. Int J Pharm Sci 
Rev Res 2016;37:190-9.
6. Lenin S, Rao MR, Prabhu K, Bindu R, Elizabeth AA, Dinakar S. The 
study of antioxidant activities of an Ayurvedic medicine Ayaskriti. 
Pharm Lett 2016;8:203-11.
7. Sharada NS, Rao MR, Priya M, Prabbu K, Kalaivani KV, Kumaran D, 
et al. The study of antioxidant activities of an Ayurvedic medicine 
Kulathadi Kashayam. Pharm Lett 2016;8:245-8.
8. Rao MR, Ravi A, Narayanan S, Prabhu SK, Kalaiselvi VS, Dinakar S, 
et al. Antioxidant Study and GC MS analysis of an ayurvedic medicine 
‘talisapatradi choornam’. Int J Pharm Sci Rev Res 2016;36:158-66.
9. Rao MR, Phillips S, Kumar MH, Saranya Y, Divya D, Prabhu K. GC 
MS analysis, antimicrobial, antioxidant activity of an ayurvedic 
medicine, salmali niryasa. J Chem Pharm Res 2015;7:131-9.
10. Chandrasekar T, Rao MR, Kumar RV, Prabhu K, Kumar SN, Divya D. 
GC-MS analysis, antimicrobial, antioxidant activity of an ayurvedic 
medicine, nimbapatradi choornam. J Chem Pharm Res 2015;7:124-36.
11. Phillips S, Rao MR, Prabhu K, Priya M, Kalaivani S, Ravi A, et al. 
Preliminary GC-MS analysis of an ayurvedic medicine “kulathadi 
kashayam.” J Chem Pharm Res 2015;7:393-401.
12. Rao MR, Kumar SN, Jones S, Elizabeth AA, Prabhu K, Ravi A, et al. 
Phytochemical and GC MS analysis of an ayurvedic formulation, 
patolakaturohinyadi kwatham. Int J Pharm Sci Rev Res 2015;34:6-12.
13. Ravi A, Mohammad H, Rao MR, Prabhu K, Babu H, Shridhar. 
Antibacterial, antioxidant activity and GC MS analysis of a sidha 
medicine “neerkovai tablets”. Int Journ Pharm Tech 2015;7:10091-112.
14. Rao MR, Kumar MH, Amutha A, Prabhu K, Chatterjee B, Kumar SS. 
Phytochemical analysis and antioxidant efficacy of the resin of Bombax 
ceiba (Salmali). Int J Pharm Sci Rev Res 2015;30:335-9.
15. Rao MR, Ganesan A, Rengasundari G, Kumar MS, Jha NK. Treatment 
of peptic ulcer in animal model by Sirucinni Uppu (Herbal salt of 
Acalypha fruticosa Forssk.). Pharm Lett 2014;6:20-6.
16. Rao MR, Ganesan A, Rengasundari G, Kumar MS, Jha NK. The clinical 
efficacy of ‘Kodasuri veeravaippu’ (a sidhha formulation) in patients 
affected by the disease “Keelvayu” (Arthritis). Pharm Lett 2014;6:71-7.
17. Rao MR, Ganesan A, Rengasundari G, Kumar MS. The curative role 
of Acalypha fruticosa Forrssk. (Sirucinni uppu) salt on peptic ulcer 
patients. Pharm Lett 2014;6:44-51.
18. Velpandian V, Anbu N, Selangovan S, Musthafa MM. Antihypertensive 
activity of Ardostachys jatamansi in hypertensive rats following renal 
gold blatt occlusion method. World J Pharm Res 2014;3:769-77.
19. Parekar RR, Jadhav KS, Marathe PA, Rege NN. Effect of 
Saraswatarishta in animal models of behavior despair. J Ayurveda 
Integr Med 2014;5:141-7.
20. Sandhiya S, Kumar MP, Velpandian V, Thenmozhi P, Banumathi V. 
Standardization of Siddha polyherbal formulation vaeppampoovathy 
mathirai. Am J Pharm and Health Res 2014;10:129-37.
21. Rao MR, Ganesan A, Rengasundari G, Kumar MS, Jha NK. ‘Kodasuri 
veeravaippu’ a sidha preparation, against carrageenan induced paw 
edema and cotton pellet induced granuloma in albino rats. Pharm Lett 
2013;5:99-104.
22. Kumar MS, Rao MR, Ganesan A, Rengasundari G. Antibacterial 
screening of kodasuri veeravaippu, a siddha salt preparation. Int 
J Pharm Sci Rev Res 2013;20:140-1.
23. Velpandian V, Kumar MP, Gnanavel IS, Anbu N, Khader AM. Clinical 
evaluation of kodipavala chunnam in the treatment of Infective 
hepatitis, drug induced hepatitis and alchoholic hepatitis. Int Res 
J Pharm 2013;4:152-7.
24. Kanimozhi B, Arumugam K, Velpandian V, Kumar MP. Diuretic 
activity of siddha formulation ashta gunma triaavagam in rat. Int 
J Pharm Phytopharm Res 2013;2:340-3.
25. Gupta K, Ashok BK, Ravishankar B, Thakar AB. Anti-anxiety and anti-
depressant activities of sarasvata choorna in experimental animals. Ayu 
2011;32:590-3.
26. Pandey N, Chaurasia JK, Tiwari OP, Tripathi YB. Antioxidant 
properties of different fractions of tubers from Pueraria tuberosa Linn. 
Food Chem 2007;105:19-22.
27. Govindarajan R, Vijayakumar M, Pushpangadan P. Antioxidant 
approach to disease management and the role of rasayana herbs of 
ayurveda. J Ethnopharmacol 2005;99:165-78.
28. Balakrishnan BB, Krishnasamy K. Evaluation of free radical screening 
and antioxidant potential of Moringa concanensis nimmo-a medicinal 
plant used in Indian traditional medication system. Int J Pharm Pharm 
Sci 2018;10:91-7.
29. Tambewagh UU, Rojatkar SR. In vitro antioxidant and in vivo anti-
inflammatory activity of the aerial part of Blumea eriantha DC. Int J 
Pharm Pharm Sci 2018;10:75-9.
30. Bihani GV, Rojatkar SR, Bodhankar SL. Investigation of in vivo 
analgesic and anti-inflammatory activity in rodents and in vitro anti-
oxidant activity of extracts of whole plant of Cyathocline purpurea. Int 
J Pharm Pharm Sci 2014;6:492-8.
31. Arulpriya P, Lalitha P, Hemalatha S. In vitro antioxidant testing of the 
extracts of Samanea saman (Jacq.)Merr. Chem Sinica 2010;1:73-9.
32. Oyedemi SO, Afolayan AJ. In vitro and in vivo antioxidant activity of 
aqueous extracts of Leonotis leonurus. Int J Pharmacol 2011;7:248-56.
33. Fan H, Yang GZ, Zheng T, Mei ZN, Liu XM, Chen Y, et al. Chemical 
constituents with free-radical-scavenging activities from the stem of 
Microcos paniculata. Molecules 2010;15:5547-60.
34. Ravi A, Prabhu SP, Rao MR, Prabhu K, Kalaiselvi VS, Saranya Y. 
Identification of Active Biomolecules in saraswatarishtam (an 
ayurvedic preparation) by GC-MS analysis. Int J Pharm Sci Rev Res 
2015;33:58-62.
35. Ravi A, Gupta M, Rao MR, Kalaiselvi VS, Prabhu K, Dinakar S, et al. 
GC MS analysis of an ayurvedic medicine “ashokarishtam”. Pharm Lett 
2015;7:45-52.
36. Sadhanandham S, Narayanan G, Rao MR, Prabhu K, Jones S, Ravi A, 
et al. GC-MS analysis and antioxidant studies of an ayurvedic drug, 
partharishtam. Int J Pharm Sci Rev Res 2015;34:273-81.
37. Uddin Q, Samiulla L, Singh VK, Jamil SS. Phytochemical and 
pharmacological profile of Withania somnifera Dunal: A review. J Appl 
Pharm Sci 2012;2:170-5.
38. Tohda C, Kuboyama T, Komatsu K. Search for natural products related 
to regeneration of the neuronal network. Neurosignals 2005;14:34-45.
39. Ghosal S, Lal J, Srivastava R, Bhattacharya SK, Upadhyay SN, 
Jaiswal AK, et al. Immunomodulatory and CNS effects of sitoindosides 
IX and X, two new glycowithanolides from Withania somnifera. 
Phytother Res 1989;3:201-6.
40. Patil VN, Deokule SS. Pharmacognostic study of Chlorophytum 
tuberosum Baker. Int J Ayurveda Res 2010;1:237-42.
41. Mariselvam R, Ranjitsingh AJ, Nanthini AU. Preparation and 
characterization of silver nanoparticles using Rubia cordifolia plant 
root extract and their microbial properties. Int J Adv Res 2013;1:56-61.
42. Gorle AM, Patil SS. Evaluation of antioxidant and antiacne property of 
Rubia cordifolia. Pharm Sinica 2013;1:59-63.
43. Lodia S, Kansala L. Antioxidant activity of Rubia cordifolia against 
lead toxicity. Int J Pharm Sci Res 2012;3:2224-32.
44. Bag A, Bhattacharya SK, Chattopadhyay RR. The development of 
Terminalia chebula Retz. (Combretaceae) in clinical research. Asian 
Pac J Trop Biomed 2013;3:244-52.
45. Sharma K, Bairwa R, Chauhan N, Srivastava B, Saini NK. Berberis 
aristata: A review. Int J Res Ayurveda Pharm 2011;2:383-8.
46. Damle M. Glycyrrhiza glabra (Liquorice) - A potent medicinal herb. Int 
J Herb Med 2014;2:132-6.
47. Pandey N, Yadav D, Pandey V, Tripathi YB. Anti-inflammatory effect 
of Pueraria tuberosa extracts through improvement in activity of red 
blood cell anti-oxidant enzymes. Ayu 2013;3:297-301.
48. Kumar SV, Sujatha C, Shymala J, Nagasudha B, Mishra SH. Protective 
effect of root extract of Operculina terpethum Linn. against paracetamol 
induced hepatotoxicity in rats. Indian J Pharm Sci 2006;68:32-5.
231
Asian J Pharm Clin Res, Vol 11, Issue 11, 2018, 227-231
 Kotteswari et al. 
49. Anbuselvam C, Vijayavel K, Balsubramaniyan MP. Protective effect 
of Operculina turpethum against 7, 12 dimethylbenz (a)anthracene 
induced oxidative stress with reference to breast cancer in experimental 
rats. Chem Biol Interact 2007;168:229-36.
50. Chatterjee S, Banerjee A, Chandra I. Hemidesmus indicus: A rich 
source of herbal medicine. Med Aromat Plants 2014;3:e155.
51. Azamthulla M, Balasubramanian R, Kavimani S. A review on 
Pterocarpus santalinus linn. World J Pharm Res 2015;4:282-92.
52. Adel PR, Prakash J. Chemical composition and antioxidant properties 
of ginger root (Zingiber officinalis). J Med Plants Res 2010;4:2674-9.
53. Kumar S, Kamboj J, Suman, Sharma S. Overview for various aspects 
of the health benefits of Piper longum Linn. fruit. J Acupunct Meridian 
Stud 2011;4:134-40.
54. Sharma PC, Yelne MB, Dennis TJ. Database on Medicinal Plants 
Used in Ayurveda. Vol. 5. New Delhi: Central Council for Research in 
Ayurveda & Siddha; 2002.
55. Preety A, Sharma S. A brief review on Cinnamomum tamala (Buch.-
Ham.) Nees and Eberm.: An important medicinal tree. Int J Res Biol Sci 
2016;6:26-31.
56. Jayanthi G, Kamalraj S, Karthikeyan K, Muthumary J. Antimicrobial 
and antioxidant activity of the endophytic fungus Phomopsis sp. 
GJJM07 isolated from Mesua ferrea. Int J Curr Sci 2011;1:85-90.
